Shopping News / Articles
In A World First, Fully AI-Designed, Needle-Free, "Universal" Coronavirus Vaccine Completes Human Trials
55+ min ago (810+ words) SARS-Co V-2, shown here in green, mutates readily to produce seemingly endless new variants. This vaccine offers the hope of protecting us from all of them. Image credit: National Institute of Allergy and Infectious Diseases/NIH via Flickr (public domain) Universal…...
Marjorie Taylor receives stem cell therapy with Brian Glenn in Mexico.
1+ hour, 16+ min ago (11+ words) The Greatest News Site On The Internet. Home of CFP Nation....
ATS 2026: promising Phase I interim results with KB407 in cystic fibrosis
4+ day, 1+ hour ago (667+ words) KB407s positive set of results presented at ATS 2026 follows a set of similar positive results that were announced for the first two cohorts in December 2024. On May 20, at the American Thoracic Society (ATS) international conference, during a poster session, Krystal Biotech…...
Fracture in Telesurgery: The Role of Three-Dimensional Modeling in Prevention
11+ hour, 18+ min ago (279+ words) Foro3 D The recent incident of a broken arm during remote surgery has raised alarms in the biomedical community. Although telesurgery promises global access to specialists, the lack of precise haptic feedback can lead to excessive forces on bone tissue. This…...
Retatrutide benefits in obesity, type 2 diabetes "quite staggering
6+ hour, 28+ min ago (1338+ words) NEW ORLEANS "A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options, according to data from two phase 3 trials. During a symposium at the American…...
Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation
2+ week, 2+ day ago (142+ words) REDWOOD CITY, Calif. , May 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted. .. Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation REDWOOD CITY, Calif....
Eli Lilly's new weight loss drug may also help sleep apnea according to Phase 3 data
3+ hour, 45+ min ago (230+ words) Eli Lilly has unveiled promising trial results for its experimental obesity drug, retatrutide, demonstrating its potential to significantly reduce sleep apnea severity, alleviate knee pain, and aid in weight loss. The findings, presented to medical professionals on Saturday, highlight the…...
Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
8+ hour, 3+ min ago (90+ words) Welcome back! The American Diabetes Association annual conference is in full swing with news about old and new approaches to treating diabetes. Buckle in for a day 2 recap. Liz covers cardiovascular and metabolic disease, asking why we're not doing better…...
Lilly shares safety, tolerability data on its next-gen obesity drug
10+ hour, 25+ min ago (205+ words) Eli Lilly has already established that its next-generation obesity drug can lead to highly rapid weight loss. Researchers disclosed new data Saturday that provide more details on the safety and tolerability of the closely-watched therapy. Lilly previously said that in…...
Two drugs synergize, may help cystic fibrosis, Stanford Medicine-led study shows
5+ day, 11+ hour ago (765+ words) Drugs synergize in cystic fibrosis Two existing types of drugs synergize to improve the clearing of mucus from the lungs of animals with cystic fibrosis, a Stanford Medicine research team has found. The findings appear in the June 2026 issue of…...
Shopping
Please enter a search for detailed shopping results.